Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials …
Biotechnology
US, Westlake Village [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Arcutis Biotherapeutics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDArcutis Biotherapeutics, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Arcutis Biotherapeutics, Inc..
If you want to see a demo, head over to the financial segments of AAPL